Publication
Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.
Avirup Guha, Ana Barac, Michael James Ryan, Randala Hamdan, Geeta Devgan, Catherine H Marshall, Silke Gillessen, Stacy Loeb, Rana R McKay, Emmanuel S Antonarakis, Zachary Klaassen, Meenakshi Davuluri, Alan H Bryce, Yun Rose Li, Nader El-Chaar, Stephanie Braun, Maha Hussain, Pedro Barata, Martin W Schoen, Cora N Sternberg, Tamara Jamaspishvili, Samuel L Washington, Neal D Shore, David Morris, Jack R Andrews, Irbaz Bin Riaz, Daniel George, Soumyajit Roy, Gina B Carithers, Phillip Koo, Neeraj Agarwal, Andrew W Hahn
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
IMPORTANCE: Cardiovascular disease (CVD) is a leading noncancer cause of death among patients with prostate cancer (PC). Population-based risk calculators do not account for treatment-related effects of androgen-deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPis), and they…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available